Insulet logo

Insulet

PODD | NASDAQ
Chart Builder DCF Calculator
$145.38
-$7.10 (-4.66%)
At close: Nov 16, 2026, 4:00 PM ET
$145.29
-$0.09 (-0.06%)
After-hours: Nov 16, 2026, 7:30 PM ET
-4.66%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
84.7
Fundamentals Excellent
Market Sentiment Bullish
Moat Narrow
Sector Rank #7/1021 (Top 1%)

Key Statistics

Market Data

Market Cap $10.09B
1D Range
144.88 155.39
52W Range
130.47 346.36

Valuation (TTM)

PE 23.68
PB 6.39
EV/EBITDA 15.25

Valuation (NTM)

Forward PE 22.39
Forward PEG 0.63
Price Target $175.00
Loading financial charts...

Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform ...

Sector Healthcare
Employees 5,400
IPO Date May 15, 2007
Fiscal Year January - December

Latest News

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

4 days ago · zacks.com

Why Insulet (PODD) is a Top Growth Stock for the Long-Term
Insulet (PODD) Just Overtook the 20-Day Moving Average

4 days ago · zacks.com

Insulet (PODD) Just Overtook the 20-Day Moving Average
Insulet: Rivals Are Building Patch Pumps, But Insulet Already Owns The Pharmacy Counter

5 days ago · seekingalpha.com

Insulet: Rivals Are Building Patch Pumps, But Insulet Already Owns The Pharmacy Counter
Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think "Yes"

6 days ago · zacks.com

Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think "Yes"
For World Diabetes Day, Insulet Launches “Give Yourself the Freedom to” Campaign, Encouraging People with Diabetes to Prioritize Their Well-Being

8 days ago · businesswire.com

For World Diabetes Day, Insulet Launches “Give Yourself the Freedom to” Campaign, Encouraging People with Diabetes to Prioritize Their Well-Being
What Insulet (PODD) Said on Its Q3 Earnings Call

12 days ago · marketbeat.com

What Insulet (PODD) Said on Its Q3 Earnings Call
Insulet Corporation (PODD) Q3 2026 Earnings Call Transcript

13 days ago · seekingalpha.com

Insulet Corporation (PODD) Q3 2026 Earnings Call Transcript
Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

13 days ago · zacks.com

Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Insulet (PODD) Q3 Earnings and Revenues Surpass Estimates

13 days ago · zacks.com

Insulet (PODD) Q3 Earnings and Revenues Surpass Estimates
Insulet to Participate in the 2026 Jefferies Global Healthcare Conference in London

14 days ago · businesswire.com

Insulet to Participate in the 2026 Jefferies Global Healthcare Conference in London

Earnings

Latest Earnings
Nov 4, 2026
EPS
$1.99
Beat +25.16%
REV
$842M
Beat +1.13%
Next Earnings
Feb 17, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
20
Consensus
Hold
Price Target
$175.00
Upside
+20.37%
Buy (10)
Hold (10)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.